Scotland · NHS Scotland MSAN
Mirtazapine 15mg and 45mg orodispersible tablets
MSAN(2020)57 · Level 2 · issued 26 Jun 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Mirtazapine 15mg and 45mg orodispersible tablets are out of stock until late July 2020. | Out of stock | late July 2020 |
| 3. Mirtazapine 30mg orodispersible tablets remain available but cannot support any increase in | Available — cannot support uplift | — |
| 4. Mirtazapine 15mg, 30mg and 45mg tablets remain available. | Available | — |
| 5. Mirtazapine 15mg/ml oral suspension remains available but cannot support any increase in | Available — cannot support uplift | — |
| switching to an alternative antidepressant which is available in a suitable formulation using | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2020:57
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
1ad50e70071c5ff2a1784861721ffeb04dacae1712f1adc7f8517826815848a1sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2020-57.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.